Deutsche Bank Ag\ Infinity Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.49 - $1.2 $25,969 - $63,598	-52,999 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.85 - $2.4 $4,792 - $13,531	-5,638 Reduced 9.62%	52,999 $60,000
Q4 2021 Feb 11, 2022	SELL	$1.86 - $3.36 $531,561 - $960,240	-285,786 Reduced 82.98%	58,637 $132,000
Q3 2021 Nov 04, 2021	BUY	$1.52 - $3.82 $5,009 - $12,590	3,296 Added 0.97%	344,423 $1.18 Million
Q2 2021 Aug 11, 2021	SELL	$2.66 - $3.47 $47,153 - $61,512	-17,727 Reduced 4.94%	341,127 $1.02 Million
Q1 2021 May 13, 2021	BUY	$1.98 - $5.36 $710,530 - $1.92 Million	358,854 New	358,854 $1.16 Million
Q2 2018 Aug 14, 2018	SELL	$1.72 - $2.26 $213 - $280	-124 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$1.8 - $2.74 $178 - $271	-99 Reduced 44.39%	124 $0
Q4 2017 Feb 14, 2018	SELL	$1.22 - $3.73 $909,442 - $2.78 Million	-745,445 Reduced 99.97%	223 $0
Q3 2017 Nov 14, 2017	BUY	$0.94 - $1.35 $700,927 - $1.01 Million	745,668	745,668 $990,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.